FDA Approves First Over-the-Counter Naloxone Nasal Spray

Upcoming Events

Pneumococcal Vaccine Update for Physicians and Clinicians – April 30

Please join us for a pneumococcal vaccine update webinar on Tuesday, April 30, noon - 1:00 p.m. and hear from Lynn Fisher, MD, family physician and Gretchen Homan, MD, pediatrician, who will provide updates impacting adult pneumococcal vaccine recommendations for adult and pediatric patients, respectively and Monica Pando, RN, VFC coordinator, who will discuss navigating these updates from a clinic perspective.

careLearning Informational Webinar - May 1

In this webinar you will gain practical knowledge of how the careLearning system will help you organize and manage your education. careLearning is non-profit member service of The Kansas Hospital Association and over 40 other state hospital associations.

KARQM Education Program - May 2

The Kansas Association of Risk and Quality Management was created to promote the delivery of quality health care and the practice of risk management in Kansas health care facilities. Membership includes risk and quality management professionals in health care facilities or health-related organizations.

Educational Webinar: How Do Your Hospital Finances Measure Up? – May 2

Join Healthworks and KHA for an educational session at 2:00 p.m. on May 2 to learn how to utilize QHis financial benchmarking tool effectively. Shannan Flach, vice president health care finance and reimbursement and Sally Othmer, vice president data and strategic analytics will be joined by Wes Garrison, founder, Databasically to walk through the tool including the easy-upload process, reviewing the QHi financial measures available and to demonstrating how to run and schedule reports.

Opioid Educational Webinar: Partnering to Increase Access to SUD Treatment – May 3

Please join us on May 3 to hear how hospitals and communities are partnering to increase access to substance use disorder treatment and harm reduction. The program has been approved for 1.0 contact hours of continuing nursing education and pending approval for 1.0 contact hours of continuing pharmacy education. There is no charge to attend as this program is funded through a grant from our partners at DCCCA.

Current Report Articles

‹‹ Back To List

FDA Approves First Over-the-Counter Naloxone Nasal Spray

(March 31, 2023) – The Food and Drug Administration announced on March 29 the agency's approval of Narcan nasal spray (4-milligram naloxone hydrochloride nasal spray) for over-the-counter use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose. The FDA's action allows Narcan nasal spray to be sold directly to consumers in pharmacies, convenience stores, grocery stores and gas stations, as well as online. Expected OTC availability, according to Emergent BioSolutions, the manufacturer, is late summer of this year. In the meantime, the prescription product will remain available through current access channels, including pharmacies through standing order or co-prescription laws and through community distribution.
--Karen Braman

‹‹ Back To List

Communications

Upcoming Events

Recent News